Technavio

Discover Market Opportunities

Category: Healthcare and Life Sciences

Renewable energy

Global liver diseases therapeutics market expected to reach US $45 million by 2019, says Technavio

iradmin05 mins

  This market research report from Technavio segments the global liver diseases therapeutics market by disease indication (hepatitis, liver cirrhosis, and liver cancer), by type of molecule (biologics and small molecules), and by geography (Americas, EMEA, and APAC). Leading vendors analyzed in this market study are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson,…

Read More
Renewable energy

Promising Late-Stage Pipeline Molecules Encouraging Growth Prospects in the Global Preventive Asthma Drugs Market: Technavio Report

iradmin03 mins

  The key vendors in the global preventive asthma drugs market 2015-2019 are AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Merck, and Novartis. London, 29 September 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global preventive asthma drugs market 2015-2019.   Biologics are increasingly becoming the…

Read More